Overview


According to FutureWise analysis the market for marine biotechnology in 2023 is US$ 6.33 billion, and is expected to reach US$ 11.13 billion by 2031 at a CAGR of 7.31%.

The MMR report explores the rising interest in marine biotechnology due to recent scientific advances that have increased our knowledge of marine biodiversity and allowed for the development of technology and tools that can access and study marine ecosystems and organisms. There are many industrially useful items that have been recently introduced to the market. This has raised the possibility of significant benefits over the forecast period. But, even though marine bioresources have great potential to provide new goods and processes, they are still largely untapped. Marine biotechnology, a cutting-edge area of engineering and science, involves the use marine bioresources to produce food, fuel, materials or specific compounds. It can support sustainable industries and green growth as well as prosperous communities. Marine biotechnology uses genetic engineering and other cultivation techniques to mass produce valuable marine compounds. This is done while keeping the marine ecosystem in good health. The rise of the "circular economy" is expected to drive global market growth. The market is seeing an increase in marine ingredients used in agriculture, food and cosmetics.
Global bioplastics and biopolymers markets are increasingly looking to marine biotechnology for new biodegradable biopolymers. Recent research shows that it is possible to convert biowastes from crabs, shrimps, and prawns into the naturally occurring biopolymers "chitin” and "chitosan." New methods of producing microbial energies and microbial power conversion hold great promise for using forest biomass inventories to generate electricity. The advancements in bio-processing, phenomics and other nutritional and sustainability benefits will play an important role in increasing microalgae adoption in the food supplement, nutraceuticals, and nutraceuticals sectors. In the next few years, peptide therapeutics will grow due to new discoveries and improved marine peptides. Research shows that the use of marine-based ingredients in cosmetics and agriculture is highly in demand, which will help to grow the marine biotechnology market. The demand for nutritional supplements made with marine-derived products is increasing, which has led to the expansion of the marine biotechnology industry.

The key driver of market growth is discovery and advancement in the fields aquaculture, fishery, as well as drug discovery and development. Bluu Biosciences has received funding to produce fish products from cell cultures. The industry is seeing increased awareness and demand for aquatic organisms for their healthy management. Marine biotechnology market growth is driven by the sector's ability and willingness to address critical social issues such as sustainability in food and energy security, human health and well-being, and greening industrial products and processes. Market growth has also been facilitated by recent innovations in science, technology, especially post-genomic technologies. Bioprospecting has also led to a significant increase of the number of natural products from marine organisms and genes that are of economic value in recent years.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Marine Biotechnology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Marine Biotechnology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Aker BioMarine AS
  • BASF SE
  • CP Kelco
  • Cyanotech Corp.
  • GlycoMar Ltd
  • Lonza Group
  • Marinova Pty Ltd
  • New England Biolabs Inc
  • NovaMatrix
  • Nutrex Hawaii Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Marine Animal Technology
  • Marine Plant Technology
  • Marine Biotechnology

By Application

  • Cosmetics
  • Pharmaceuticals
  • Fine Chemical
  • Nutritional Supplements

By End-use Industry

  • Pharmaceutical
  • Biotechnology

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Marine Biotechnology Market By Product Type, By Application, By End-use Industry and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Marine Biotechnology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Marine Biotechnology Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Marine Biotechnology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Marine Biotechnology Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Marine Animal Technology
        2. Marine Plant Technology
        3. Marine Biotechnology

  • 8.   Marine Biotechnology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cosmetics
        2. Pharmaceuticals
        3. Fine Chemical
        4. Nutritional Supplements

  • 9.   Marine Biotechnology Market, By End-use Industry Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical
        2. Biotechnology

  • 10.   North America Marine Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Marine Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Marine Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Marine Biotechnology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Aker BioMarine AS
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BASF SE
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CP Kelco
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cyanotech Corp.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GlycoMar Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Lonza Group
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Marinova Pty Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. New England Biolabs Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. NovaMatrix
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Nutrex Hawaii Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients